论文部分内容阅读
目的:探讨磺胺嘧啶银对烧伤患者的临床治疗效果。方法:随机抽取本院从2009年2月~2013年2月期间,收治过的烧伤患者中的52例,按性别、年龄、烧伤程度等对他们进行编号,并按照入院时间随机的分成两组(观察组和对照组),每组各26例。对观察组的患者采用磺胺嘧啶银进行治疗;对对照组的患者利用碘伏进行治疗,并对两组患者的临床治疗效果情况进行比较和分析。结果:比较显示,在愈合时间方面,观察组的患者(11.9±2.15d)较之对照组的患者(19.2±1.96d)明显较短;在疼痛感率方面,观察组的患者(61.54%,16/26)较之对照组的患者(96.15%,25/26)明显较低;在患者满意度方面,观察组的患者(65.38%,17/26)较之对照组的患者(34.61%,9/26)明显较高。组间比较存在显著性差异,且均具有统计学意义(P<0.01,P<0.05)。结论:在烧伤患者的临床诊疗过程中,应用磺胺嘧啶银进行治疗,其疗效显著,应当作为烧伤病症的临床外用药物。
Objective: To investigate the clinical effect of silver sulfadiazine on burn patients. Methods: 52 cases of burn patients were randomly selected from February 2009 to February 2013 in our hospital. The patients were numbered according to sex, age and degree of burn, and were randomly divided into two groups according to admission time (Observation group and control group), each group of 26 cases. Patients in the observation group were treated with silver sulfadiazine; patients in the control group were treated with iodophor and the clinical effects of the two groups were compared and analyzed. Results: The comparison showed that the patients in the observation group (11.9 ± 2.15 days) were significantly shorter than those in the control group (19.2 ± 1.96 days) in terms of healing time. In terms of pain sensitivity, patients in the observation group (61.54% 16/26) were significantly lower than those in the control group (96.15%, 25/26). In terms of patient satisfaction, patients in the observation group (65.38%, 17/26) 9/26) is significantly higher. There was significant difference between the two groups (P <0.01, P <0.05). Conclusion: In the clinical diagnosis and treatment of patients with burn, the application of sulfadiazine silver treatment, its significant effect, should be used as a clinical drug burn disease.